Join the 'Migraine Prevention' group to help and get support from people like you.
Migraine Prevention News
Health Tip: Understanding Migraines
Posted 13 days ago by Drugs.com
-- A migraine headache can be so painful that it prevents you from doing most daily activities. About 12 percent of Americans get frequent migraines, the U.S. National Library of Medicine says. Sufferers are more likely to be women, have a family history of migraines or have other medical conditions, such as depression, anxiety, bipolar disorder, sleep disorder or epilepsy. The agency says common ...
Study Hints at Why Women Suffer More Migraines Than Men
Posted 14 Aug 2018 by Drugs.com
TUESDAY, Aug. 14, 2018 – New insight into why women get more migraines than men could lead to better treatments, researchers say. The results of lab and animal experiments suggest changing levels of the female sex hormone estrogen make cells around a key nerve in the head and connected blood vessels more sensitive to migraine triggers. And that increases migraine risk. The study was published ...
When Does Your Child's Headache Call for a Doctor Visit?
Posted 16 Jul 2018 by Drugs.com
MONDAY, July 16, 2018 – Headaches are common in children and teens, but many parents aren't sure when to seek professional help for their child, a new survey finds. The survey of parents with children aged 6 to 18 found that two-thirds said their child has had a headache not caused by a fall or head injury. "Headaches are very common in children and usually not dangerous or disruptive," said ...
To Fend Off Migraines, Try Keeping a Headache Diary
Posted 15 Jul 2018 by Drugs.com
SATURDAY, July 14, 2018 – A migraine diary may help you pinpoint – and avoid – headache triggers, a neurologist says. About 12 percent of people in the United States suffer from migraines, according to the Migraine Research Foundation. "A migraine can be debilitating and can impact daily activities, your family and social life. Unfortunately, migraine often goes undiagnosed and undertreated," ...
Could Estrogen Play a Role in Men's Migraines?
Posted 27 Jun 2018 by Drugs.com
WEDNESDAY, June 27, 2018 – Many women with migraines have headaches triggered by hormonal fluctuations. Now a small study hints that estrogen could play a role in men's migraines, too. The study of 39 men found that those with migraines had higher estrogen levels, on average, than men who were migraine-free. On the other hand, both groups of men had similar testosterone levels. For the migraine ...
Non-Drug Migraine Treatments Often Ignored
Posted 5 Jun 2018 by Drugs.com
TUESDAY, June 5, 2018 – Many migraine sufferers skip recommended behavioral treatments, such as stress management and talk therapy, a new study finds. Lack of time, cost and skepticism are among the reasons why, said Dr. Mia Minen, director of research for NYU Langone's headache division in New York City. Previous studies have shown that treatments such as cognitive behavioral therapy, stress ...
Trials Report Galcanezumab Shows Promise At Preventing Migraines
Posted 29 May 2018 by Drugs.com
TUESDAY, May 29, 2018 – Migraine sufferers could soon turn to a number of new medications to avoid their crippling headaches. Earlier this month, the U.S. Food and Drug Administration approved Aimovig (erenumab), the first migraine prevention drug ever developed. On its heels comes a successful trial of the migraine prevention drug galcanezumab. Galcanezumab cut in half the number of days that ...
FDA Approves Aimovig (erenumab), The First Drug Aimed at Preventing Migraines
Posted 18 May 2018 by Drugs.com
FRIDAY, May 18, 2018 – The millions of Americans who suffer from migraine may have a new source of hope – the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday. Researchers have found that the injected drug, called Aimovig (erenumab), can prevent migraines if other treatments have failed to do so. "Aimovig provides patients with a novel ...
Aimovig Approved to Prevent Migraines
Posted 18 May 2018 by Drugs.com
FRIDAY, May 18, 2018 – Aimovig (erenumab-aooe) has been approved by the U.S. Food and Drug Administration to prevent migraine headaches in adults. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule involved in migraine attacks, the agency said in a news release. "We need new ...
FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine
Posted 18 May 2018 by Drugs.com
May 17, 2018 – The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine ...
The Cold Truth About Migraine Headaches
Posted 3 May 2018 by Drugs.com
THURSDAY, May 3, 2018 – Early humans' ability to adapt to cold climates may have been helped by a genetic variant that's common in modern people who live in colder regions – and is linked with migraine headaches, researchers say. Within the last 50,000 years, humans left Africa and colonized cold areas in Asia, Europe, and other parts of the world. And this colonization could have triggered ...
New Therapy Aimovig (erenumab) in Development to Prevent Tough-to-Treat Migraines
Posted 18 Apr 2018 by Drugs.com
TUESDAY, April 17, 2018 – The millions of Americans who suffer from migraine may have a new source of hope – the first of a new class of drugs that harness the immune system to ward off the headaches. Researchers found that the injected drug, called erenumab, could prevent migraines if other treatments fail to do so. Erenumab (brand name Aimovig) works by blocking a key brain "neurotransmitter" ...
'Magnetic Pulse' Device May Be New Way to Prevent Migraines
Posted 5 Apr 2018 by Drugs.com
THURSDAY, April 5, 2018 – Self-administered magnetic pulses from a hand-held device may help head off debilitating migraines, researchers report. This new way to approach migraine headaches is called "single pulse transcranial magnetic stimulation" (sTMS). Neurologists and psychiatrists have long used the technology to diagnose and treat patients. The U.S. Food and Drug Administration had ...
Migraines Tied to Higher Heart Trouble Risk
Posted 1 Feb 2018 by Drugs.com
WEDNESDAY, Jan. 31, 2018 – Migraine sufferers might have to worry about more than just dealing with debilitating headaches. Migraine patients could also face an increased risk of heart attacks, strokes, blood clots and irregular heart rates, a new study suggests. The risk to heart health appears to be strongest in the first year after diagnosis of migraine, but persists for as long as two ...
Another Legacy of Terror Attacks: Migraines
Posted 13 Dec 2017 by Drugs.com
WEDNESDAY, Dec. 13, 2017 – Survivors of terror attacks may be at risk of developing frequent migraines or tension-type headaches, a new study suggests. Norwegian researchers examined the aftermath of a 2011 terrorist attack on a summer camp in Norway that left 69 people dead and 33 severely wounded. Most of the dead were teenagers. The investigators followed more than 200 of the young survivors, ...
Further Information
Related Condition Support Groups
Related Drug Support Groups
lisinopril, clonazepam, bupropion, metoprolol, amitriptyline, Topamax, amlodipine, Depakote, atenolol, view more... propranolol, lamotrigine, clonidine, baclofen, nortriptyline, topiramate, Benicar, pregabalin, Botox, Norvasc, verapamil, Depakote ER, Inderal, nifedipine, timolol, divalproex sodium, nadolol, zonisamide, valproic acid, Zonegran, olmesartan, Inderal LA, candesartan, Aimovig, Tenormin, Depakote Sprinkles, Corgard, phenelzine, acebutolol, Lioresal, riboflavin, feverfew, Ajovy, Calan, fremanezumab, Isoptin, captopril, Qudexy XR, Isoptin SR, Topamax Sprinkle, InnoPran XL, onabotulinumtoxina, Calan SR, Stavzor, Vitamin B2, Topiragen, Kemstro, galcanezumab, Isoptin IV, Covera-HS, Verelan, Verelan PM, Blocadren, erenumab, nimodipine, Emgality
